1. Home
  2. CPHI vs SOBR Comparison

CPHI vs SOBR Comparison

Compare CPHI & SOBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPHI
  • SOBR
  • Stock Information
  • Founded
  • CPHI N/A
  • SOBR 2004
  • Country
  • CPHI China
  • SOBR United States
  • Employees
  • CPHI N/A
  • SOBR N/A
  • Industry
  • CPHI Biotechnology: Pharmaceutical Preparations
  • SOBR Newspapers/Magazines
  • Sector
  • CPHI Health Care
  • SOBR Consumer Discretionary
  • Exchange
  • CPHI Nasdaq
  • SOBR Nasdaq
  • Market Cap
  • CPHI 4.7M
  • SOBR 5.2M
  • IPO Year
  • CPHI N/A
  • SOBR N/A
  • Fundamental
  • Price
  • CPHI $1.78
  • SOBR $3.56
  • Analyst Decision
  • CPHI
  • SOBR
  • Analyst Count
  • CPHI 0
  • SOBR 0
  • Target Price
  • CPHI N/A
  • SOBR N/A
  • AVG Volume (30 Days)
  • CPHI 14.2K
  • SOBR 83.8K
  • Earning Date
  • CPHI 11-12-2025
  • SOBR 11-13-2025
  • Dividend Yield
  • CPHI N/A
  • SOBR N/A
  • EPS Growth
  • CPHI N/A
  • SOBR N/A
  • EPS
  • CPHI N/A
  • SOBR N/A
  • Revenue
  • CPHI $4,396,201.00
  • SOBR $301,400.00
  • Revenue This Year
  • CPHI N/A
  • SOBR N/A
  • Revenue Next Year
  • CPHI N/A
  • SOBR N/A
  • P/E Ratio
  • CPHI N/A
  • SOBR N/A
  • Revenue Growth
  • CPHI N/A
  • SOBR 73.21
  • 52 Week Low
  • CPHI $1.20
  • SOBR $2.41
  • 52 Week High
  • CPHI $3.35
  • SOBR $98.14
  • Technical
  • Relative Strength Index (RSI)
  • CPHI 46.82
  • SOBR 53.58
  • Support Level
  • CPHI $1.64
  • SOBR $3.10
  • Resistance Level
  • CPHI $1.93
  • SOBR $3.47
  • Average True Range (ATR)
  • CPHI 0.08
  • SOBR 0.32
  • MACD
  • CPHI -0.03
  • SOBR -0.00
  • Stochastic Oscillator
  • CPHI 38.89
  • SOBR 54.34

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

About SOBR SOBR Safe Inc.

Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.

Share on Social Networks: